Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization.

Romo N, Magri G, Muntasell A, Heredia G, Baía D, Angulo A, Guma M, López-Botet M.

J Leukoc Biol. 2011 Oct;90(4):717-26. doi: 10.1189/jlb.0311171. Epub 2011 Jul 8.

PMID:
21742939
2.

NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.

Magri G, Muntasell A, Romo N, Sáez-Borderías A, Pende D, Geraghty DE, Hengel H, Angulo A, Moretta A, López-Botet M.

Blood. 2011 Jan 20;117(3):848-56. doi: 10.1182/blood-2010-08-301374. Epub 2010 Oct 28.

3.

Human cytomegalovirus infection of M1 and M2 macrophages triggers inflammation and autologous T-cell proliferation.

Bayer C, Varani S, Wang L, Walther P, Zhou S, Straschewski S, Bachem M, Söderberg-Naucler C, Mertens T, Frascaroli G.

J Virol. 2013 Jan;87(1):67-79. doi: 10.1128/JVI.01585-12. Epub 2012 Oct 10.

4.

Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection.

Muntasell A, Magri G, Pende D, Angulo A, López-Botet M.

Blood. 2010 Jun 24;115(25):5170-9. doi: 10.1182/blood-2009-11-256479. Epub 2010 Apr 14.

5.

HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.

Cederarv M, Söderberg-Nauclér C, Odeberg J.

Immunobiology. 2009;214(5):331-41. doi: 10.1016/j.imbio.2008.10.009. Epub 2009 Jan 18.

PMID:
19152985
6.

Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation.

Verreck FA, de Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH.

J Leukoc Biol. 2006 Feb;79(2):285-93. Epub 2005 Dec 5.

PMID:
16330536
7.

Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.

Gumá M, Budt M, Sáez A, Brckalo T, Hengel H, Angulo A, López-Botet M.

Blood. 2006 May 1;107(9):3624-31. Epub 2005 Dec 29.

8.

Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages.

Wu Z, Frascaroli G, Bayer C, Schmal T, Mertens T.

J Virol. 2015 Jun;89(12):6435-41. doi: 10.1128/JVI.00435-15. Epub 2015 Apr 8.

9.

Cytomegalovirus infection stimulates expression of monocyte-associated mediator genes.

Dudding L, Haskill S, Clark BD, Auron PE, Sporn S, Huang ES.

J Immunol. 1989 Nov 15;143(10):3343-52.

PMID:
2553812
10.

Antibody-mediated response of NKG2Cbright NK cells against human cytomegalovirus.

Costa-Garcia M, Vera A, Moraru M, Vilches C, López-Botet M, Muntasell A.

J Immunol. 2015 Mar 15;194(6):2715-24. doi: 10.4049/jimmunol.1402281. Epub 2015 Feb 9.

11.

Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus.

Schrier RD, Rice GP, Oldstone MB.

J Infect Dis. 1986 Jun;153(6):1084-91.

PMID:
2422296
14.
16.

Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses.

Wu Z, Sinzger C, Reichel JJ, Just M, Mertens T.

J Virol. 2015 Mar;89(5):2906-17. doi: 10.1128/JVI.03489-14. Epub 2014 Dec 24.

17.

UL40-mediated NK evasion during productive infection with human cytomegalovirus.

Wang EC, McSharry B, Retiere C, Tomasec P, Williams S, Borysiewicz LK, Braud VM, Wilkinson GW.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7570-5.

18.

Apoptosis induced by human cytomegalovirus infection can be enhanced by cytokines to limit the spread of virus.

Chaudhuri AR, St Jeor S, Maciejewski JP.

Exp Hematol. 1999 Jul;27(7):1194-203.

PMID:
10390195
19.

Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma.

Shibata Y, Foster LA, Kurimoto M, Okamura H, Nakamura RM, Kawajiri K, Justice JP, Van Scott MR, Myrvik QN, Metzger WJ.

J Immunol. 1998 Oct 15;161(8):4283-8.

Supplemental Content

Support Center